Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 131,329 | 259,393 | 467,443 | 85,749 | 80,428 |
| Marketable Securities | 510,094 | 389,434 | 197,410 | 272,381 | 282,046 |
| Receivables | 6,259 | 40,309 | 6,152 | 7,896 | 37,591 |
| TOTAL | $659,668 | $700,294 | $679,400 | $370,948 | $405,473 |
| Non-Current Assets | |||||
| PPE Net | 41,324 | 35,282 | 33,907 | 31,294 | 29,926 |
| Investments And Advances | 50,530 | 45,761 | 0 | 5,000 | 21,832 |
| Intangibles | 100,926 | 96,553 | 92,537 | 90,687 | 92,429 |
| Other Non-Current Assets | 86,102 | 85,820 | 88,815 | 86,347 | 87,856 |
| TOTAL | $278,882 | $263,416 | $215,259 | $213,328 | $232,043 |
| Total Assets | $938,550 | $963,710 | $894,659 | $584,276 | $637,516 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,553 | 17,897 | 19,221 | 16,923 | 6,671 |
| Accrued Expenses | 20,738 | 17,873 | 13,332 | 8,592 | 13,605 |
| TOTAL | $143,547 | $123,561 | $93,942 | $62,065 | $69,872 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 91,644 | 87,791 | 61,389 | 36,550 | 38,711 |
| Other Non-Current Liabilities | 45,478 | 44,455 | 45,325 | 46,139 | 46,957 |
| TOTAL | $297,637 | $319,268 | $289,511 | $127,796 | $134,905 |
| Total Liabilities | $441,184 | $442,829 | $383,453 | $189,861 | $204,777 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143,251 | 141,441 | 140,988 | 140,883 | 116,023 |
| Common Shares | 1,421 | 1,412 | 1,410 | 1,163 | 1,160 |
| Retained earnings | -777,981 | -737,377 | -735,827 | -699,898 | -656,985 |
| Other shareholders' equity | 4,551 | 1,023 | -1,904 | -3,704 | -2,264 |
| TOTAL | $497,366 | $520,881 | $511,206 | $394,415 | $432,739 |
| Total Liabilities And Equity | $938,550 | $963,710 | $894,659 | $584,276 | $637,516 |